- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/401 - ProlineDerivatives thereof, e.g. captopril
Patent holdings for IPC class A61K 31/401
Total number of patents in this class: 975
10-year publication summary
|
66
|
64
|
84
|
64
|
78
|
74
|
77
|
49
|
59
|
57
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Azurity Pharmaceuticals, Inc. | 213 |
20 |
| Exela Pharma Sciences, LLC | 22 |
18 |
| ThermoLife International, LLC | 130 |
18 |
| Boehringer Ingelheim Vetmedica GmbH | 1278 |
11 |
| Ajinomoto Co., Inc. | 2306 |
11 |
| Novartis AG | 10656 |
10 |
| F. Hoffmann-La Roche AG | 7932 |
10 |
| Société des Produits Nestlé S.A. | 9856 |
9 |
| The Regents of the University of California | 20230 |
9 |
| Takeda Pharmaceutical Company Limited | 2717 |
9 |
| ADT Pharmaceuticals, LLC | 13 |
9 |
| Stealth Biotherapeutics Inc. | 167 |
9 |
| Merck Sharp & Dohme LLC | 3734 |
9 |
| University of Florida Research Foundation, Inc. | 4074 |
8 |
| APR Applied Pharma Research SA | 64 |
8 |
| Enanta Pharmaceuticals, Inc. | 433 |
8 |
| Pfizer Inc. | 3397 |
7 |
| Convergence Pharmaceuticals Limited | 33 |
7 |
| Bristol-myers Squibb Company | 4848 |
6 |
| AstraZeneca AB | 2857 |
6 |
| Other owners | 773 |